Citenamide

CAS No. 10423-37-7

Citenamide( —— )

Catalog No. M33319 CAS No. 10423-37-7

Citenamide (AY-15613) has anticancer and anticonvulsant activity and is used in the study of neurological disorders because of its sleep-promoting properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 248 Get Quote
5MG 312 Get Quote
10MG 528 Get Quote
25MG 994 Get Quote
50MG 1334 Get Quote
100MG 1764 Get Quote
500MG 3528 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Citenamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Citenamide (AY-15613) has anticancer and anticonvulsant activity and is used in the study of neurological disorders because of its sleep-promoting properties.
  • Description
    Citenamide is an anticonvulsant.
  • In Vitro
    ——
  • In Vivo
    Citenamide (Cytenamide, CYT) is an analogue of Carbamazepine (CBZ), a dibenzazepine drug used to control seizures.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10423-37-7
  • Formula Weight
    235.28
  • Molecular Formula
    C16H13NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N)C1C=2C=CC=CC2C=CC=3C=CC=CC31
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Johnston A, et al. Cytenamide-formic acid (1/1). Acta Crystallogr Sect E Struct Rep Online. 2008 Jul 5;64(Pt 8):o1379-80.?
molnova catalog
related products
  • PDD00017272

    PDD00017272 (34f) is a potent inhibitor of poly(ADP-ribose) glycohydrolase (PARG), exhibiting an EC50 value of 4.8 nM in biochemical assays and 9.2 nM in cellular POM.

  • Cobalt phthalocyanin...

    Cobalt phthalocyanine is a catalyst for a redox reaction.

  • BMS-P5 free base

    BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor.?BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.